Dr. Debralynne Zickafoose, MD

Dr. Zickafoose practices at Murrieta Specialty Care Surgery Center in Murrieta, California.

Dr. Zickafoose's NPI, 1265406797, was assigned on February 13, 2006. Dr. Zickafoose graduated from George Washington University School of Medicine and Health Sciences in 1994. Dr. Zickafoose's California license number on file is A54704.

Dr. Zickafoose's primary practice is Murrieta Specialty Care Surgery Center, at 39755 Date St, Murrieta, CA 92563 in Riverside County. The practice phone is (951) 279-0100.

Dr. Zickafoose's primary practice is Murrieta Specialty Care Surgery Center in Murrieta, California. Dr. Zickafoose is also affiliated with Loma Linda University Medical Center - Murrieta. The medical group on file is Tri-Valley Medical Group. Dmand AI also links Dr. Zickafoose to 1 more hospital, 5 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zickafoose practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Zickafoose's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Zickafoose is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Zickafoose's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, acute kidney failure, acute mini-stroke (TIA), acute sinusitis, acute skin infection, ADHD and adjustment disease among the conditions Dr. Zickafoose treats.

CMS data shows 3,077 Medicare services from Dr. Zickafoose across 21 procedure codes in 2024, for 814 Medicare patients. Medicare paid $253,653 for them.

CMS counts 814 Medicare patients who saw Dr. Zickafoose in 2024. The largest group is 65 to 74, with 368 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zickafoose's median patient age at 73, with 66% women.

In 2024, Dr. Zickafoose wrote 11,626 Medicare Part D claims for 947 patients. 87% of them were for generic drugs. CMS names the drug for 10,818 of them, across 158 drugs with 11 or more claims each, at $868,627 in total drug cost. In 2023, CMS named 10,776 claims across 163 drugs.

Dr. Zickafoose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zickafoose as offering telehealth. CMS counts 17 procedures of removal of skin lesions by Dr. Zickafoose, more than 63% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 337 general payments to Dr. Zickafoose from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $807.

Dr. Zickafoose graduated from George Washington University School of Medicine and Health Sciences in 1994. Dr. Zickafoose is a member of ACP and SHM.

Dr. Zickafoose is in network with 12 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.